Resources - Search Results | Barrington James

Back to resources

Displaying 1 - 8 of 85

Biotechnology
Why the Latest IPO Wave Won’t Be Won on Science Alone.
IPO activity does more than unlock capitalIn the last cycle, the path to public markets was ...

By Barrington James March 20th, 2026
The Peptide Shift Is a Stress Test for 503B Infrastructure
Over the weekend, HHS Secretary Robert F. Kennedy Jr. publicly stated an intent to...

By Ethan Dumoulin March 12th, 2026
Biotechnology
Navigating Cell & Gene Therapy Hiring Trends and the 2026 Outlook.
Market Context: From Breakthrough Momentum to Operational Discipline When the fir...

By Brandon Schelkle March 12th, 2026
Pharmaceutical, Biotechnology
Celebrating Women in Life Sciences: Driving Discovery, Innovation and Change
Scientific progress has always depended on bold ideas, but also on the people courageous eno...

By Barrington James March 8th, 2026
The Diversity Gap in Life Sciences: Progress, Pressure, and the Talent Challenge Companies Can’t Ignore
The life sciences industry exists to solve some of the world’s most complex problems. ...

By Barrington James March 6th, 2026
The People Bottleneck Quietly Slowing Drug Development
The industry often frames drug development as a race against biology. But increasingly,...

By Barrington James March 2nd, 2026
Company News
Barrington James Announces Brand Integration of S3 Science
S3 Science to formally merge into Barrington James, strengthening global Drug Discovery &...

By Barrington James February 27th, 2026
How AI Is Reshaping Medical Affairs in 2026 and What It Means for Executive Leadership
Artificial intelligence has moved from an innovation agenda item to an operational reality w...

By Barrington James February 17th, 2026